1. Mark Creswell President and CEO [email protected] Phone: 734.433.9670 Cell: 734.476.4097 Capabilities ● Expertise ● Services IDSC From Hit to the…

1. August 13-15, 2013 • Hilton Boston Back Bay Hotel • Boston, MAPreliminary Agenda Register by May 17 and Save up to $300!ImmunoTheherapies Immune System Modulation…

1. Pharmacoepidemiology Study design Information bias & selection bias Rob Heerdink 2. Dr Rob Heerdink Pharmacoepidemiology & Pharmacotherapy Utrecht Institute for…

1. SCIENCE PROJECTHow can Science help us Eradicate Disease? Genomes to Hit Molecules in Silico: A Country Path Today, A Highway Tomorrow By utkARSh veRMA KVJNU 2. Supercomputing…

Slide 1Pre-clinical Development of a Nasal Adenovirus-Based Vaccine Against Ebola Virus (CRTI 06-0218RD) Public Security S&T Symposium 2009 Slide 2 PROJECT BACKGROUND…

Slide 1TB Drug Development Gerald J. Siuta, Ph.D. Business Development May 3, 2007 Slide 2 Tuberculosis One-third of the worlds population is infected with Mycobacterium…

Slide 1ChemAxon's Java Components in a Heterogeneous, Server-Centric Application Environment ChemAxon 2005 User Group Meeting May 19th and 20th, Budapest, Hungary Mark…

Slide 11 dr.Boenjamin Setiawan, Ph.D. Future of Industrial Biotechnology dr.Boenjamin Setiawan, Ph.D.,UCSF 1.Biotechnology consists of Traditional and Modern Biotech: Medical,…

Slide 1Joseph A. DiMasi, Ph.D. Director of Economic Analysis Tufts Center for the Study of Drug Development Tufts University SLA Pharmaceutical & Health Technology Division…

Slide 1ANTICANCER AND ANTI-HIV DRUGS DERIVED FROM AFRICAN AND OTHER PLANTS Gordon Cragg, Ph.D. NIH Special Volunteer Natural Products Branch Developmental Therapeutics Program…